RELX

RELX is a multinational information and analytics company that provides critical decision-making tools to professional and business customers across various sectors. The company's offerings include risk prediction and fraud detection solutions, scientific information supporting research, legal and regulatory insights for informed legal decisions, and market-leading events. RELX has successfully transitioned from its print media heritage, with digital products now accounting for 83% of its sales. This shift has been driven by the company's strategic focus on high-growth analytics and AI-driven tools, such as Lexis+ AI, which automates tasks such as drafting and document analysis for legal professionals. The business model benefits from excellent earnings visibility due to subscription contracts and proprietary databases, creating a strong competitive moat. This has resulted in robust and accelerating revenue growth, driven by strong demand for its analytics and decision tools. Through its Scientific, Technical and Medical segment, RELX plays a crucial role in facilitating scientific progress. Platforms such as ScienceDirect offer access to over 18 million documents, supporting primary research for scientists and researchers. Elsevier, a leading academic publisher within RELX, ensures rigorous peer review processes to maintain the quality of scientific publications. This commitment to academic excellence underscores RELX's position as a key enabler of scientific advancement. Companies selected for illustrative purposes only to demonstrate the investment management style described herein and not as an investment recommendation or indication of future performance.